Evotec SE (EVO)
4.77
-0.16
(-3.25%)
USD |
NASDAQ |
May 24, 16:00
4.78
+0.01
(+0.21%)
After-Hours: 20:00
Evotec Total Liabilities (Quarterly): 1.190B for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.190B |
| December 31, 2023 | 1.252B |
| September 30, 2023 | 1.179B |
| June 30, 2023 | 1.225B |
| December 31, 2022 | 1.148B |
| September 30, 2022 | 1.016B |
| June 30, 2022 | 1.064B |
| March 31, 2022 | 976.79M |
| December 31, 2021 | 970.85M |
| September 30, 2021 | 899.12M |
| June 30, 2021 | 914.59M |
| March 31, 2021 | 923.37M |
| December 31, 2020 | 907.56M |
| September 30, 2020 | 818.19M |
| June 30, 2020 | 803.69M |
| March 31, 2020 | 765.54M |
| December 31, 2019 | 788.47M |
| September 30, 2019 | 679.76M |
| June 30, 2019 | 714.58M |
| March 31, 2019 | 485.77M |
| December 31, 2018 | 396.94M |
| September 30, 2018 | 441.66M |
| June 30, 2018 | 393.93M |
| March 31, 2018 | 401.94M |
| December 31, 2017 | 401.37M |
| Date | Value |
|---|---|
| September 30, 2017 | 383.73M |
| June 30, 2017 | 122.71M |
| March 31, 2017 | 112.65M |
| December 31, 2016 | 148.18M |
| September 30, 2016 | 92.39M |
| June 30, 2016 | 94.99M |
| March 31, 2016 | 104.59M |
| December 31, 2015 | 110.91M |
| September 30, 2015 | 120.52M |
| June 30, 2015 | 123.52M |
| March 31, 2015 | 70.03M |
| December 31, 2014 | 80.52M |
| September 30, 2014 | 73.63M |
| June 30, 2014 | 86.91M |
| March 31, 2014 | 87.56M |
| December 31, 2013 | 94.47M |
| September 30, 2013 | 92.01M |
| June 30, 2013 | 91.07M |
| March 31, 2013 | 92.93M |
| December 31, 2012 | 96.38M |
| September 30, 2012 | 89.28M |
| June 30, 2012 | 80.08M |
| March 31, 2012 | 91.90M |
| December 31, 2011 | 91.92M |
| September 30, 2011 | 86.54M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
679.76M
Minimum
Sep 2019
1.252B
Maximum
Dec 2023
959.77M
Average
923.37M
Median
Mar 2021
Total Liabilities (Quarterly) Benchmarks
| Centogene NV | 113.23M |
| Affimed NV | 43.50M |
| InflaRx NV | 13.32M |
| MorphoSys AG | 2.186B |
| BioNTech SE | 2.471B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.385B |
| Shareholders Equity (Quarterly) | 1.195B |
| Debt to Equity Ratio | 0.5671 |
| Current Ratio | 1.865 |
| Net Debt Paydown Yield | -2.34% |